• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菲律宾新生血管性年龄相关性黄斑变性患者眼中的息肉状脉络膜血管病变特征:亚太眼成像学会非吲哚青绿血管造影标准的应用

Polypoidal choroidal vasculopathy features among Filipino eyes with neovascular AMD: application of the Asia Pacific Ocular Smaging Society non-ICGA criteria.

作者信息

Lacanilao Jonathan Paul B, Artiaga Jose Carlo M

机构信息

Department of Ophthalmology and Visual Sciences, Sentro Oftalmologico Jose Rizal, Philippine General Hospital, University of the Philippines Manila, Taft Avenue, 1000, Manila City, Philippines.

International Eye Institute, St Luke's Medical Center Global City, Taguig City, Philippines.

出版信息

Int Ophthalmol. 2025 Aug 25;45(1):351. doi: 10.1007/s10792-025-03715-y.

DOI:10.1007/s10792-025-03715-y
PMID:40853572
Abstract

BACKGROUND/OBJECTIVES: To determine the proportion of eyes with optical coherence tomography (OCT) features of polypoidal choroidal vasculopathy (PCV) among patients diagnosed as neovascular age-related macular degeneration (nAMD) based on Asia-Pacific Ocular Imaging Society (APOIS) Diagnostic Criteria.

METHODS

This study was a retrospective cross-sectional review of OCT images. Medical records of treatment-naïve nAMD patients between January 2018 and June 2023 were reviewed. Clinical and demographic profile at presentation was collected. OCT scans were reviewed for presence of APOIS Diagnostic Criteria. Eyes were classified as having PCV features (PCV) based on the presence of ≥ 2 major OCT APOIS diagnostic criteria and then compared with eyes not having these features (non-PCV).

RESULTS

OCT scans of 45 eyes of 38 patients diagnosed with nAMD were analyzed. Mean age was 69.4 years old (range 53-83), 71.1% of patients were female, and 81.6% had unilateral disease. There was no statistically significant difference among clinical and demographic characteristics between PCV and non-PCV groups. Twenty-four eyes (53.3%) had ≥ 2 major APOIS criteria for PCV. Among PCV eyes, sub-RPE ring-like lesion and double-layer sign were the most common major (87.5%) and minor OCT criteria (100%), respectively. Sharp-peaked PED (p < 0.001), sub-RPE ring-like lesion (p < 0.001), en face OCT complex RPE elevation (p = 0.005) and double-layer sign criteria (p = 0.007) were more frequent in the PCV than in the non-PCV group.

CONCLUSION

More than half of Filipino eyes diagnosed with nAMD fulfill the OCT criteria for PCV. The APOIS PCV Workgroup Criteria helps identify patients who will benefit from additional confirmatory and treatment options.

摘要

背景/目的:根据亚太眼成像协会(APOIS)诊断标准,确定在被诊断为新生血管性年龄相关性黄斑变性(nAMD)的患者中,具有息肉状脉络膜血管病变(PCV)光学相干断层扫描(OCT)特征的眼睛比例。

方法

本研究是对OCT图像的回顾性横断面分析。回顾了2018年1月至2023年6月间未经治疗的nAMD患者的病历。收集了就诊时的临床和人口统计学资料。对OCT扫描结果进行评估,以确定是否符合APOIS诊断标准。根据是否存在≥2项主要OCT APOIS诊断标准,将眼睛分为具有PCV特征(PCV)的眼睛,并与不具有这些特征的眼睛(非PCV)进行比较。

结果

分析了38例诊断为nAMD患者的45只眼睛的OCT扫描结果。平均年龄为69.4岁(范围53 - 83岁),71.1%的患者为女性,81.6%为单眼患病。PCV组和非PCV组在临床和人口统计学特征上无统计学显著差异。24只眼睛(53.3%)具有≥2项PCV的主要APOIS标准。在PCV眼中,视网膜色素上皮(RPE)下环状病变和双层征分别是最常见的主要OCT标准(87.5%)和次要OCT标准(100%)。尖锐峰值的视网膜色素上皮脱离(p < 0.001)、RPE下环状病变(p < 0.001)、OCT正面复杂RPE隆起(p = 0.005)和双层征标准(p = 0.007)在PCV组中比非PCV组更常见。

结论

超过一半被诊断为nAMD的菲律宾人眼睛符合PCV的OCT标准。APOIS PCV工作组标准有助于识别将从额外的确诊和治疗选择中获益的患者。

相似文献

1
Polypoidal choroidal vasculopathy features among Filipino eyes with neovascular AMD: application of the Asia Pacific Ocular Smaging Society non-ICGA criteria.菲律宾新生血管性年龄相关性黄斑变性患者眼中的息肉状脉络膜血管病变特征:亚太眼成像学会非吲哚青绿血管造影标准的应用
Int Ophthalmol. 2025 Aug 25;45(1):351. doi: 10.1007/s10792-025-03715-y.
2
Clinical features and classification framework of polypoidal choroidal vasculopathy in Saudi populations.沙特人群中息肉状脉络膜血管病变的临床特征及分类框架
Int Ophthalmol. 2025 Aug 5;45(1):323. doi: 10.1007/s10792-025-03685-1.
3
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.非 ICGA 治疗标准用于治疗脉络膜息肉样血管病变的抗 VEGF 反应不佳:APOIS PCV 工作组报告 2。
Ophthalmol Retina. 2021 Oct;5(10):945-953. doi: 10.1016/j.oret.2021.04.002. Epub 2021 Apr 16.
4
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.息肉样脉络膜血管病变:亚太眼影像学学会 PCV 工作组的共识命名和非吲哚菁绿血管造影诊断标准。
Ophthalmology. 2021 Mar;128(3):443-452. doi: 10.1016/j.ophtha.2020.08.006. Epub 2020 Aug 11.
5
Proton beam irradiation with anti-VEGF therapy for polypoidal choroidal vasculopathy: results of a 24-month, phase II randomized study.质子束照射联合抗血管内皮生长因子治疗息肉样脉络膜血管病变:一项为期24个月的II期随机研究结果
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):659-668. doi: 10.1007/s00417-024-06681-w. Epub 2024 Nov 9.
6
Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.单侧新生血管性年龄相关性黄斑变性患者治疗眼与未治疗对侧眼脉络膜厚度的比较:配对眼比较研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 8. doi: 10.1007/s00417-025-06751-7.
7
Responsiveness of anti-VEGF treatment for polypoidal choroidal vasculopathy based on aqueous humour proteomics: A preliminary study.基于房水蛋白质组学的抗VEGF治疗息肉样脉络膜血管病变的反应性:一项初步研究。
Acta Ophthalmol. 2025 Mar;103(2):e136-e145. doi: 10.1111/aos.16768. Epub 2024 Oct 18.
8
Pneumatic displacement of submacular haemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.继发于新生血管性年龄相关性黄斑变性和息肉样脉络膜血管病变的黄斑下出血的气动移位。
Eye (Lond). 2024 Dec;38(17):3374-3381. doi: 10.1038/s41433-024-03318-4. Epub 2024 Sep 19.
9
Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration.基于非吲哚青绿造影标准的白人患者中与年龄相关的湿性黄斑变性的息肉样脉络膜血管病变。
Am J Ophthalmol. 2022 Dec;244:58-67. doi: 10.1016/j.ajo.2022.07.024. Epub 2022 Aug 8.
10
Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.典型新生血管性年龄相关性黄斑变性与息肉样脉络膜血管病变的黄斑中心凹下脉络膜结构比较。
Jpn J Ophthalmol. 2018 Sep;62(5):576-583. doi: 10.1007/s10384-018-0615-4. Epub 2018 Aug 1.

本文引用的文献

1
Sociodemographic disparities in ophthalmological clinical trials.眼科临床试验中的社会人口统计学差异。
BMJ Open Ophthalmol. 2023 Feb;8(1). doi: 10.1136/bmjophth-2022-001175.
2
Polypoidal Choroidal Vasculopathy: Updates on Risk Factors, Diagnosis, and Treatments.息肉样脉络膜血管病变:危险因素、诊断及治疗的最新进展
Asia Pac J Ophthalmol (Phila). 2023;12(2):184-195. doi: 10.1097/APO.0000000000000573. Epub 2023 Mar 14.
3
Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration.
基于非吲哚青绿造影标准的白人患者中与年龄相关的湿性黄斑变性的息肉样脉络膜血管病变。
Am J Ophthalmol. 2022 Dec;244:58-67. doi: 10.1016/j.ajo.2022.07.024. Epub 2022 Aug 8.
4
Patterns of attendances to the hospital emergency eye care service: a multicentre study in England.医院急诊眼科护理服务的就诊模式:英格兰的一项多中心研究。
Eye (Lond). 2022 Dec;36(12):2304-2311. doi: 10.1038/s41433-021-01849-8. Epub 2021 Nov 30.
5
Prevalence of Polypoidal Choroidal Vasculopathy Using Non-indocyanine green angiography-based Criteria.基于非吲哚菁绿血管造影标准的息肉样脉络膜血管病变患病率
Ophthalmol Retina. 2022 Feb;6(2):179-181. doi: 10.1016/j.oret.2021.09.009. Epub 2021 Sep 24.
6
Multimodal Imaging Comparison of Polypoidal Choroidal Vasculopathy Between Asian and Caucasian Populations.亚洲和白种人群中息肉样脉络膜血管病变的多模态成像比较
Am J Ophthalmol. 2022 Feb;234:108-116. doi: 10.1016/j.ajo.2021.08.006. Epub 2021 Aug 24.
7
Long-term outcomes of polypoidal choroidal vasculopathy in comparison with typical exudative age-related macular degeneration.息肉样脉络膜血管病变与典型渗出性年龄相关性黄斑变性的长期疗效比较。
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):83-92. doi: 10.1007/s00417-021-05190-4. Epub 2021 Aug 5.
8
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.息肉样脉络膜血管病变:亚太眼影像学学会 PCV 工作组的共识命名和非吲哚菁绿血管造影诊断标准。
Ophthalmology. 2021 Mar;128(3):443-452. doi: 10.1016/j.ophtha.2020.08.006. Epub 2020 Aug 11.
9
Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.抗 VEGF 治疗伴或不伴光动力疗法治疗息肉状脉络膜血管病变的比较: EVEREST II 随机临床试验。
JAMA Ophthalmol. 2020 Sep 1;138(9):935-942. doi: 10.1001/jamaophthalmol.2020.2443.
10
A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography.吲哚菁绿血管造影与扫频源光学相干断层扫描血管成像对视盘旁脉络膜新生血管的对比研究。
Am J Ophthalmol. 2020 Sep;217:240-251. doi: 10.1016/j.ajo.2020.05.017. Epub 2020 May 21.